Text Size
141 studies found for:    Open Studies | "Lupus Erythematosus, Systemic"

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Lupus Erythematosus, Systemic" (141 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Systemic;   Arthritis, Rheumatoid
Intervention:
2 Unknown † Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Procedure: Hematopoietic Cell Transplantation
3 Recruiting Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
Conditions: Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic
Interventions: Drug: R932333;   Drug: Placebo
4 Unknown † Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention:
5 Recruiting Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus
Conditions: Immune System Diseases;   Autoimmune Diseases;   Lupus Erythematosus, Systemic;   Skin and Connective Tissue Diseases;   Connective Tissue Disease
Interventions: Biological: CDP7657;   Other: Placebo
6 Recruiting A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Biological: Belimumab plus Early Vaccination;   Biological: Belimumab plus Late Vaccination
7 Recruiting Study of Systemic Lupus Erythematosus
Conditions: Lupus Nephritis;   Systemic Lupus Erythematosus
Intervention:
8 Not yet recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Intervention: Drug: milatuzumab
9 Recruiting CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: blisibimod;   Drug: Placebo
10 Recruiting Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC)
Condition: Systemic Lupus
Intervention: Drug: Arsenic trioxide
11 Unknown † Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)
Condition: Refractory Systemic Lupus Erythematosus
Intervention: Biological: Allogeneic MSC (AlloMSC)
12 Unknown † Cardiology Prevention in Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Other: Preventive Cardiology;   Other: Usual Care
13 Recruiting Zostavax in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Zostavax vaccine
14 Recruiting International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
15 Recruiting Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
Condition: Systemic Lupus Erythematosus
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
16 Recruiting Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Conditions: Systemic Lupus Erythematosus;   Antiphospholipid Syndrome
Intervention:
17 Unknown † Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Dehydroepiandrosterone (DHEA)
18 Recruiting A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus;   Connective Tissue Disease;   Autoimmune Disease
Interventions: Drug: LY2127399;   Drug: Placebo every 2 weeks;   Drug: Placebo every 4 weeks
19 Recruiting A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus;   Connective Tissue Disease;   Autoimmune Disease
Interventions: Drug: LY2127399;   Drug: Placebo every 2 weeks;   Drug: Placebo every 4 weeks
20 Recruiting Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
Conditions: Antiphospholipid Syndrome;   Thrombophilia Due to Antiphospholipid Antibody;   Systemic Lupus Erythematosus
Intervention: Other: Phlebotomy
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years